321 related articles for article (PubMed ID: 33239445)
1. Tolerogenic nanoparticles suppress central nervous system inflammation.
Kenison JE; Jhaveri A; Li Z; Khadse N; Tjon E; Tezza S; Nowakowska D; Plasencia A; Stanton VP; Sherr DH; Quintana FJ
Proc Natl Acad Sci U S A; 2020 Dec; 117(50):32017-32028. PubMed ID: 33239445
[TBL] [Abstract][Full Text] [Related]
2. IFN-β Facilitates Neuroantigen-Dependent Induction of CD25+ FOXP3+ Regulatory T Cells That Suppress Experimental Autoimmune Encephalomyelitis.
Wang D; Ghosh D; Islam SM; Moorman CD; Thomason AE; Wilkinson DS; Mannie MD
J Immunol; 2016 Oct; 197(8):2992-3007. PubMed ID: 27619998
[TBL] [Abstract][Full Text] [Related]
3. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
Front Immunol; 2018; 9():3119. PubMed ID: 30687323
[TBL] [Abstract][Full Text] [Related]
4. Direct modulation of myelin-autoreactive CD4
Pei W; Wan X; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
Int J Nanomedicine; 2018; 13():3731-3750. PubMed ID: 29983566
[TBL] [Abstract][Full Text] [Related]
5. Galectin-1 is essential for the induction of MOG35-55 -based intravenous tolerance in experimental autoimmune encephalomyelitis.
Mari ER; Rasouli J; Ciric B; Moore JN; Conejo-Garcia JR; Rajasagi N; Zhang GX; Rabinovich GA; Rostami A
Eur J Immunol; 2016 Jul; 46(7):1783-96. PubMed ID: 27151444
[TBL] [Abstract][Full Text] [Related]
6. Intravenous Injection of Myelin Oligodendrocyte Glycoprotein-coated PLGA Microparticles Have Tolerogenic Effects in Experimental Autoimmune Encephalomyelitis.
Gholamzad M; Ebtekar M; Shafiee Ardestani M
Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):271-281. PubMed ID: 28732440
[TBL] [Abstract][Full Text] [Related]
7. Smek1 deficiency exacerbates experimental autoimmune encephalomyelitis by activating proinflammatory microglia and suppressing the IDO1-AhR pathway.
Duan RN; Yang CL; Du T; Liu A; Wang AR; Sun WJ; Li X; Li JX; Yan CZ; Liu QJ
J Neuroinflammation; 2021 Jun; 18(1):145. PubMed ID: 34183017
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA.
Derdelinckx J; Mansilla MJ; De Laere M; Lee WP; Navarro-Barriuso J; Wens I; Nkansah I; Daans J; De Reu H; Jolanta Keliris A; Van Audekerke J; Vanreusel V; Pieters Z; Van der Linden A; Verhoye M; Molenberghs G; Hens N; Goossens H; Willekens B; Cras P; Ponsaerts P; Berneman ZN; Martínez-Cáceres EM; Cools N
J Neuroinflammation; 2019 Aug; 16(1):167. PubMed ID: 31416452
[TBL] [Abstract][Full Text] [Related]
9. Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen.
Yu P; Gregg RK; Bell JJ; Ellis JS; Divekar R; Lee HH; Jain R; Waldner H; Hardaway JC; Collins M; Kuchroo VK; Zaghouani H
J Immunol; 2005 Jun; 174(11):6772-80. PubMed ID: 15905518
[TBL] [Abstract][Full Text] [Related]
10. Selective depletion of CD11c
Wang L; Li Z; Ciric B; Safavi F; Zhang GX; Rostami A
Eur J Immunol; 2016 Oct; 46(10):2454-2466. PubMed ID: 27338697
[TBL] [Abstract][Full Text] [Related]
11. Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells.
Rouse M; Singh NP; Nagarkatti PS; Nagarkatti M
Br J Pharmacol; 2013 Jul; 169(6):1305-21. PubMed ID: 23586923
[TBL] [Abstract][Full Text] [Related]
12. A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4
Moorman CD; Bastian AG; DeOca KB; Mannie MD
J Neuroinflammation; 2020 Jun; 17(1):180. PubMed ID: 32522287
[TBL] [Abstract][Full Text] [Related]
13. An endogenous aryl hydrocarbon receptor ligand acts on dendritic cells and T cells to suppress experimental autoimmune encephalomyelitis.
Quintana FJ; Murugaiyan G; Farez MF; Mitsdoerffer M; Tukpah AM; Burns EJ; Weiner HL
Proc Natl Acad Sci U S A; 2010 Nov; 107(48):20768-73. PubMed ID: 21068375
[TBL] [Abstract][Full Text] [Related]
14. Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.
Kim YC; Zhang AH; Yoon J; Culp WE; Lees JR; Wucherpfennig KW; Scott DW
J Autoimmun; 2018 Aug; 92():77-86. PubMed ID: 29857928
[TBL] [Abstract][Full Text] [Related]
15. Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression.
De Paula Pohl A; Schmidt A; Zhang AH; Maldonado T; Königs C; Scott DW
Cell Immunol; 2020 Dec; 358():104222. PubMed ID: 33053469
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation By Subchronic Low Dose 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Experimental Autoimmune Encephalomyelitis in the Absence of Pertussis Toxin.
Yang EJ; Stokes JV; Kummari E; Eells J; Kaplan BL
Toxicol Sci; 2016 May; 151(1):35-43. PubMed ID: 26822306
[TBL] [Abstract][Full Text] [Related]
17. GM-CSF-neuroantigen fusion proteins reverse experimental autoimmune encephalomyelitis and mediate tolerogenic activity in adjuvant-primed environments: association with inflammation-dependent, inhibitory antigen presentation.
Islam SM; Curtis AD; Taslim N; Wilkinson DS; Mannie MD
J Immunol; 2014 Sep; 193(5):2317-29. PubMed ID: 25049359
[TBL] [Abstract][Full Text] [Related]
18. Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE).
Abbott DJ; Blanchfield JL; Martinson DA; Russell SC; Taslim N; Curtis AD; Mannie MD
BMC Immunol; 2011 Dec; 12():72. PubMed ID: 22208499
[TBL] [Abstract][Full Text] [Related]
19. Development of PLGA Nanoparticles with a Glycosylated Myelin Oligodendrocyte Glycoprotein Epitope (MOG
Triantafyllakou I; Clemente N; Khetavat RK; Dianzani U; Tselios T
Mol Pharm; 2022 Nov; 19(11):3795-3805. PubMed ID: 36098508
[TBL] [Abstract][Full Text] [Related]
20. Liver X receptor agonist regulation of Th17 lymphocyte function in autoimmunity.
Xu J; Wagoner G; Douglas JC; Drew PD
J Leukoc Biol; 2009 Aug; 86(2):401-9. PubMed ID: 19406833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
